Nicholas Sosiak

Nicholas Sosiak is a declared insider of Cannara Biotech Inc., with filings sourced from SEDI. We count 11 filings; the first trade dates from 14 May 2021 and the latest from 2 June 2026.

Purchases make up the whole of the open-market record (9 purchases, €140k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 option exercises. 2026 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €18k. Across 9 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 5 July 2026, reports an option exercise of €57k in Cannara Biotech Inc. The latest purchase dates back some time: it was published 135 days ago, on 8 June 2026. Filings reach the SEDI feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.